ManRos Therapeutics

ManRos Therapeutics is a development-stage biotech company developing new treatments against cystic fibrosis, neurodegenerative diseases, and renal diseases.

Come and meet us

We will be happy to meet you and tell you about our research programs during the following events :

• ECFC in Belgrade, from 6th to 8th June 2018;
• NACF in Denver, from 18th to 20th October 2018.

A common research on three pathologies

ManRos Therapeutics develops novel drug candidates acting against severe pathologies, namely cystic fibrosis, neurodegenerative disorders (Alzheimer’s disease and Down syndrome), and some renal diseases (including polycystic kidney disease). Anomalies in phosphorylation are observed in the three pathologies on which ManRos Therapeutics carries out its research: they share common targets and similar mechanisms.
Science Pipeline

A leading researcher and a pharmaceutical industry expert

ManRos Therapeutics is led by a specialist in cellular and molecular biology, Dr. Laurent Meijer, and a pharmaceutical industry expert, Dr. Philippe de Lavenne.
About